FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
Haemonetics (NYSE: HAE) reported Q1 EPS of $0.50, $0.04 better than the analyst estimate of $0.46. Revenue for the quarter came in at $229 million versus the consensus estimate of $219.35 million.
GUIDANCE:
Haemonetics sees FY2022 EPS of $2.60-$3.00, versus the consensus of... More

